Martin TRUDEAU

Person

Shannon, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...
- Patent number 11,291,662
- Issue date Apr 5, 2022
- Vertex Pharmaceuticals Incorporated
- Patricia Hurter
- Y10 - TECHNICAL SUBJECTS COVERED BY FORMER USPC
Information Patent Grant
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...
- Patent number 10,537,565
- Issue date Jan 21, 2020
- Vertex Pharmaceuticals Incorporated
- Patricia Hurter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-di...
- Patent number 9,931,334
- Issue date Apr 3, 2018
- Vertex Pharmaceuticals Incorporated
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for making modulators of cystic fibrosis transmembrane cond...
- Patent number 9,751,839
- Issue date Sep 5, 2017
- Vertex Pharmaceuticals Incorporated
- John DeMattei
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...
- Patent number 9,670,163
- Issue date Jun 6, 2017
- Vertex Pharmaceuticals Incorporated
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for making modulators of cystic fibrosis transmembrane cond...
- Patent number 9,371,287
- Issue date Jun 21, 2016
- Vertex Pharmaceuticals Incorporated
- John DeMattei
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for making modulators of cystic fibrosis transmembrane cond...
- Patent number 8,835,639
- Issue date Sep 16, 2014
- Vertex Pharmaceuticals Incorporated
- John DeMattei
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for making modulators of cystic fibrosis transmembrane cond...
- Patent number 8,765,957
- Issue date Jul 1, 2014
- Vertex Pharmaceuticals Incorporated
- John DeMattei
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...
- Patent number 8,754,224
- Issue date Jun 17, 2014
- Vertex Pharmaceuticals Incorporated
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for making modulators of cystic fibrosis transmembrane cond...
- Patent number 8,476,442
- Issue date Jul 2, 2013
- Vertex Pharmaceutical Incorporated
- John DeMattei
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...
- Patent number 8,410,274
- Issue date Apr 2, 2013
- Vertex Pharmaceuticals
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Caspase inhibitors and uses thereof
- Patent number 7,652,153
- Issue date Jan 26, 2010
- Vertex Pharmaceuticals Incorporated
- Jean Damien Charrier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...
- Publication number 20230263794
- Publication date Aug 24, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...
- Publication number 20210251978
- Publication date Aug 19, 2021
- VERTEX PHARMACEUTICALS INCORPORATED
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...
- Publication number 20200352930
- Publication date Nov 12, 2020
- VERTEX PHARMACEUTICALS INCORPORATED
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...
- Publication number 20190070162
- Publication date Mar 7, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...
- Publication number 20170327456
- Publication date Nov 16, 2017
- VERTEX PHARMACEUTICALS INCORPORATED
- John DEMATTEI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...
- Publication number 20170231970
- Publication date Aug 17, 2017
- VERTEX PHARMACEUTICALS INCORPORATED
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...
- Publication number 20170096396
- Publication date Apr 6, 2017
- VERTEX PHARMACEUTICALS INCORPORATED
- John DEMATTEI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...
- Publication number 20160229806
- Publication date Aug 11, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Patricia Hurter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...
- Publication number 20150315151
- Publication date Nov 5, 2015
- VERTEX PHARMACEUTICALS INCORPORATED
- John DeMattei
- G01 - MEASURING TESTING
Information Patent Application
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...
- Publication number 20150073015
- Publication date Mar 12, 2015
- VERTEX PHARMACEUTICALS INCORPORATED
- John DeMattei
- G01 - MEASURING TESTING
Information Patent Application
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...
- Publication number 20140350281
- Publication date Nov 27, 2014
- John DeMattei
- G01 - MEASURING TESTING
Information Patent Application
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...
- Publication number 20140256770
- Publication date Sep 11, 2014
- VERTEX PHARMACEUTICALS INCORPORATED
- John DeMattei
- G01 - MEASURING TESTING
Information Patent Application
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...
- Publication number 20140242172
- Publication date Aug 28, 2014
- VERTEX PHARMACEUTICALS INCORPORATED
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...
- Publication number 20140012003
- Publication date Jan 9, 2014
- Vertex Pharmaceuticals Incorporated.
- John DeMattei
- G01 - MEASURING TESTING
Information Patent Application
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...
- Publication number 20130317060
- Publication date Nov 28, 2013
- Vertex Pharmaceuticals Incorporated.
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES AND INTERMEDIATES
- Publication number 20130066083
- Publication date Mar 14, 2013
- Vertex Pharmaceuticals Incorporated.
- Gerald J. Tanoury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...
- Publication number 20120214841
- Publication date Aug 23, 2012
- Vertex Pharmaceuticals Incorporated.
- Patricia Hurter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...
- Publication number 20120122921
- Publication date May 17, 2012
- Vertex Pharmaceuticals Incorporated.
- John DeMattei
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes and Intermediates
- Publication number 20110071298
- Publication date Mar 24, 2011
- Vertex Pharmaceuticals Incorporated.
- Gerald J. Tanoury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...
- Publication number 20100267768
- Publication date Oct 21, 2010
- Vertex Pharmaceuticals Incorporated.
- John DeMattei
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CASPASE INHIBITORS AND USES THEREOF
- Publication number 20100105914
- Publication date Apr 29, 2010
- Vertex Pharmaceuticals Incorporated.
- Jean-Damien Charrier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Martin TRUDEAU

Person

Patents Grantslast 30 patents

Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...

Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-di...

Process for making modulators of cystic fibrosis transmembrane cond...

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...

Process for making modulators of cystic fibrosis transmembrane cond...

Process for making modulators of cystic fibrosis transmembrane cond...

Process for making modulators of cystic fibrosis transmembrane cond...

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...

Process for making modulators of cystic fibrosis transmembrane cond...

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...

Caspase inhibitors and uses thereof

Patents Applicationslast 30 patents

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...

Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...

Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-d...

PROCESSES AND INTERMEDIATES

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-D...

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...

Processes and Intermediates

PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE COND...

CASPASE INHIBITORS AND USES THEREOF